发明授权
- 专利标题： Gemfibrozil containing pharmaceutical compositions
- 专利标题（中）： 含吉非贝齐的药物组合物
-
申请号： US441687申请日： 1995-05-15
-
公开(公告)号： US5726201A公开(公告)日： 1998-03-10
- 发明人: Pal Fekete , Erzsebet Fellner, nee Kohalmi , Andrea Sandorfalvy , Denes Bezzegh , Gyorgy Ujfalussy , Magdolna Gora, nee Hernyes , Imre Klebovich , Sandor Drabant , Attila Mandi , Biborka Maroshelyi, nee Kovacs , Marta Szanto , Zsuzsa Szlavy, nee Szell
- 申请人： Pal Fekete , Erzsebet Fellner, nee Kohalmi , Andrea Sandorfalvy , Denes Bezzegh , Gyorgy Ujfalussy , Magdolna Gora, nee Hernyes , Imre Klebovich , Sandor Drabant , Attila Mandi , Biborka Maroshelyi, nee Kovacs , Marta Szanto , Zsuzsa Szlavy, nee Szell
- 申请人地址： HUX Budapest
- 专利权人： Egis Gyogyszergyar Rt.
- 当前专利权人： Egis Gyogyszergyar Rt.
- 当前专利权人地址： HUX Budapest
- 主分类号： A61K9/20
- IPC分类号： A61K9/20 ; A61K9/28 ; A61K9/48 ; A61K31/19 ; A61K31/192 ; A61K47/20 ; A61P3/06 ; A61K31/34
摘要：
The invention relates to oral solid pharmaceutical composition containing as active ingredient gemfibrozil and conventional pharmaceutical auxiliary agents comprising as surfactant bis-(2-ethyl-hexyl)-sodium-sulfosuccinate in an amount of 0.05-0.5% by weight relative to gemfibrozil content of the composition. The pharmaceutical compositions according to the present invention contain a relatively small amount of a surfactant, provide uniform dissolution of the active ingredient among the different batches and the standard deviation of the dissolution rate is low.
公开/授权文献
- US4994731A Two wire and multiple output Hall-effect sensor 公开/授权日：1991-02-19